1. Home
  2. CI vs ZTS Comparison

CI vs ZTS Comparison

Compare CI & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CI

The Cigna Group

N/A

Current Price

$269.76

Market Cap

76.8B

Sector

Health Care

ML Signal

N/A

Logo Zoetis Inc.

ZTS

Zoetis Inc.

N/A

Current Price

$122.17

Market Cap

54.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CI
ZTS
Founded
1792
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.8B
54.8B
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
CI
ZTS
Price
$269.76
$122.17
Analyst Decision
Strong Buy
Buy
Analyst Count
14
11
Target Price
$345.79
$156.20
AVG Volume (30 Days)
1.5M
4.0M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
2.30%
1.75%
EPS Growth
83.00
10.05
EPS
22.18
6.02
Revenue
$274,900,000,000.00
$9,467,000,000.00
Revenue This Year
$5.75
$5.69
Revenue Next Year
$5.90
$4.81
P/E Ratio
$12.25
$20.17
Revenue Growth
11.24
2.28
52 Week Low
$239.51
$115.25
52 Week High
$350.00
$172.23

Technical Indicators

Market Signals
Indicator
CI
ZTS
Relative Strength Index (RSI) 37.78 40.31
Support Level $267.61 $117.42
Resistance Level $279.16 $130.52
Average True Range (ATR) 6.50 3.37
MACD -2.13 -0.85
Stochastic Oscillator 18.99 27.75

Price Performance

Historical Comparison
CI
ZTS

About CI The Cigna Group

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Share on Social Networks: